Pamela Stephenson - 27 Jun 2022 Form 4 Insider Report for ALBIREO PHARMA, INC.

Role
Chief Commercial Officer
Signature
/s/ Jason Duncan, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
27 Jun 2022
Net transactions value
-$8,976
Form type
4
Filing time
28 Jun 2022, 16:02:59 UTC
Previous filing
16 Jun 2022
Next filing
09 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Sale $8,976 -461 -1% $19.47 45,755 27 Jun 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 Represents 15,685 shares of common stock and 30,070 restricted stock units.